1 Min Read
Nov 28 (Reuters) - Suda Ltd:
* TO BUY GLOBAL INTELLECTUAL PROPERTY RELATING TO ANAGRELIDE, THAT HAS RECENTLY SHOWN PROMISE AS A NOVEL ANTI- CANCER AGENT Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.